(NASDAQ:VRSK), Jersey City, NJ, Jan. 08, 2026 (GLOBE NEWSWIRE) — Verisk (Nasdaq: VRSK), a leading strategic data analytics and technology partner to the global insurance industry, today announced it has sold Verisk Marketing Solutions (VMS) to ActiveProspect, the leading consent-based marketing platform. VMS, part of Verisk's underwriting division, provides leading marketing solutions for customers in […]

Aurelion Inc. (NASDAQ: AURE) (“Aurelion”) today announced that it has entered into an at-the-market (“ATM”) equity offering sales agreement (the “ATM Sales Agreement”), under which Aurelion may, from time to time, offer and sell shares of its Class A Ordinary Shares (the “Class A Ordinary Shares”) having an aggregate offering price of up to $500,000,000

reAlpha to Host Live X Spaces Fireside Chat on Real-World AI Applications in Mortgage and Real Estate Live executive conversation on practical AI use in mortgage and real estate, focused on real-world application and thoughtful adoption GlobeNewswire January 08, 2026 DUBLIN, Ohio, Jan. 08, 2026 (GLOBE NEWSWIRE) — reAlpha Tech Corp. (Nasdaq: AIRE) (the “Company”

Navient announces changes to leadership structure aligned to business strategy GlobeNewswire January 08, 2026 HERNDON, Va., Jan. 08, 2026 (GLOBE NEWSWIRE) — Navient (Nasdaq: NAVI) announced today the following changes in its leadership structure to better align with its business strategy. Steve Hauber, EVP and chief administrative officer (CAO), has been appointed EVP and chief

Verisk Announces Sale of its Marketing Solutions Business to ActiveProspect Transaction reinforces Verisk's focus on global insurance and capital allocation discipline GlobeNewswire January 08, 2026 Jersey City, NJ, Jan. 08, 2026 (GLOBE NEWSWIRE) — Verisk (Nasdaq: VRSK), a leading strategic data analytics and technology partner to the global insurance industry, today announced it has sold

Cellectis Announces 2026 Strategy and Catalysts GlobeNewswire January 08, 2026 NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, today outlined its strategic priorities and key catalysts expected for 2026.

Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax(R) (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026 GlobeNewswire January 08, 2026 GAITHERSBURG, Md., Jan. 08, 2026 (GLOBE NEWSWIRE) — Today Emergent BioSolutions (NYSE: EBS) announced it has received a delivery order valued at up to $21.5 million from the

Copa Holdings Announces Fourth Quarter Financial Results Release Schedule GlobeNewswire January 08, 2026 PANAMA CITY, Jan. 08, 2026 (GLOBE NEWSWIRE) — Copa Holdings, S.A. (NYSE: CPA) announces the following events: Earnings Release – Fourth Quarter 2025 Date: February 11, 2026 Time: After US market close This release will be available on our website: ir.copaair.com/financial-information/quarterly-results Earnings

Tulsa, Oklahoma–(Newsfile Corp. – January 8, 2026) – Educational Development Corporation (NASDAQ: EDUC) (“EDC”, or the “Company”), a publishing company specializing in books and educational products for children, today reports financial results for the fiscal third quarter ended November 30, 2025. Third Quarter Summary Compared to the Prior Year Third Quarter Net revenues were $7.0 million

(NASDAQ:CORT), Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Corcept (CORT) To Contact Him Directly To Discuss Their Options If you purchased or acquired Corcept stock and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato directly at (212)